Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:57:52.960Z.
Calculation as of: 2026-10-06T19:57:52.960Z.
Quote observation: 2026-10-06T19:55:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 65e01e2061821370315a71c231e2ba412a336584d38d2dbcbde0d0d1c3e2cd16
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Mobia Medical, Inc. Common Stock
Market Cap
$295.38M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$285.55M
PS Ratio
11.19
TTM Avg
341.11
3Y Avg
260.22
5Y Avg
137.39
Market Cap
$281.18M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $295.38M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $291.03M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.34M | N/A | N/A | N/A | N/A |
| Sagimet Biosciences Inc. (SGMT)vs › | $287.21M | N/A | 56.81 | 55.61 | 55.61 |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | 11.19 | 341.11 | 260.22 | 137.39 |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | 1.36 | 0.91 | 1.11 | 1.80 |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | N/A | 6.36 | 62.99 | 58.72 |
| Standard BioTools Inc. (LAB)vs › | $282.68M | 3.34 | 4.15 | 3.74 | 2.89 |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $281.18M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $310.91M | N/A | 995.02 | 3050.37 | 3251.65 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
